STAT1 and metabolic dysfunction-associated steatohepatitis: Therefore, the inhibition of STAT1 activation by IFN-γ receptor may be responsible for the immune-modulatory effects of genistein in NASH; however, the precise interactions between STAT1 and IFN-γ required further investigation.